Approval · Notice of Compliance 765 · 2002
ELMIRON: Notice of Compliance 765
Issued May 1, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 765
- Date
- May 1, 2002
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Glycosaminoglycan substitute
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELMIRON | 02029448 | Marketed |
Medicinal ingredients
- PENTOSAN POLYSULFATE SODIUM 100 MG per CAP